参考文献/References:
[1] Dong L, Underhill HR, Yu W, et al. Geometric and compositional appearance of atheroma in an angiographically normal carotid artery in patients with atherosclerosis[J]. Am J Neuroradiol,2010, 31(2):311-316.
[2] Eder L,Gladman DD, Ibañez D, et al. The correlation between carotid artery atherosclerosis and clinical heart disease in lupus patients[J].Lupus,2014,23(11):1142-1148.
[3] Papadopoulou SL, Neefjes LA, Garcia-Garcia HM, et al. Natural history of coronary atherosclerosis by multislice computed tomography[J]. JACC Cardiovasc Imaging,2012,5(3 Suppl):S28-S37.
[4] Zhang KY,Gai LY,Gai JJ,et al. Four-year clinical outcome in asymptomatic patients undergoing coronary computed tomography angiography[J].Chin Med J,2013,126(9):1630-1635.
[5] Fishbein MC. The vulnerable and unstable atherosclerotic plaque[J]. Cardiovasc Pathol,2010,19:6-11.
[6] Makris GC, Teng Z, Patterson AJ, et al. Advances in MRI for the evaluation of carotid atherosclerosis[J].Br J Radiol,2015,88(1052):20140282.
[7] Turan TN, Rumboldt Z, Granholm AC,et al. Intracranial atherosclerosis:correlation between in-vivo 3T high resolution MRI and pathology[J].Atherosclerosis,2014,237(2):460-463.
[8] Johri AM, Behl P, Hétu MF, et al. Carotid ultrasound maximum plaque height-A sensitive imaging biomarker for the assessment of significant coronary artery disease[J]. Echocardiography, 2015,Jun 29. doi: 10.1111/echo.13007.
[9] Brinjikji W, Huston J 3rd, Rabinstein AA, et al. Contemporary carotid imaging from degree of stenosis to plaque vulnerability[J].J Neurosurg,2015,31:1-16.
[10] Freilinger TM, Schindler A, Schmidt C, et al. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke[J].JACC Cardiovasc Imaging,2012,5(4):397-405.
[11] Nörenberg D,Ebersberger HU,Diederichs G,et al. Molecular magnetic resonance imaging of atherosclerotic vessel wall disease[J]. Eur Radiol,2015,Jul 3[Epub ahead of print].
[12] Puppini G, Furlan F, Cirota N, et al. Characterisation of carotid atherosclerotic plaque:comparison between magnetic resonance imaging and histology[J]. Radiol Med,2006,111(7):921-930.
[13] American College of Cardiology Foundation Task Force on Expert Consensus Documents, Hundley WG, Bluemke DA, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance:a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents[J]. J Am Coll Cardiol,2010,55:2414-2462.
[14] Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension[J]. Blood Press,2014,23(1):3-16.
[15] Yuk HB, Park HW, Jung IJ, et al. Analysis of carotid ultrasound findings on cardiovascular events in patients with coronary artery disease during seven-year follow-up[J].Korean Circ J,2015,45(1):28-37.
[16] Finn AV,Kolodgie FD,Virmani R.Correlation between carotid intimal/medial thickness and atherosclerosis:a point of view from pathology[J].Arterioscler Thromb Vasc Biol,2010,30(2):177-181.
[17] Underhill HR, Hatsukami TS, Cai J, et al.A noninvasive imaging approach to assess plaque severity:the carotid atherosclerosis score[J]. Am J Neuroradiol,2010,31(6):1068-1075.
[18] Gupta A, Baradaran H, Schweitzer AD, et al. Carotid plaque MRI and stroke risk:a systematic review and meta-analysis[J]. Stroke,2013,44:3071-3077.
[19] Collado S, Coll E, Nicolau C, et al. Carotid atherosclerotic disease predicts cardiovascular events in hemodialysis patients: a prospective study[J]. PLoS One,2015,10(6):e0127344.
[20] Wang J,Bornert P,Zhao H,et al. Simultaneous noncontrast angiography and intraplaque hemorrhage(SNAP)imaging for carotid atherosclerotic disease evaluation[J]. Magn Reson Med,2013,69:337-345.
[21] Staff AC,Dechend R,Redman CW.Review:preeclampsia,acute atherosis of the spiral arteries and future cardiovascular disease:two new hypotheses[J].Placenta,2013,34(Suppl):S73-S78.
[22] Qiao Y,Steinman DA,Qin Q,et al.Intracranial arterial wall imaging using three-dimensional high isotropic resolution black blood MRI at 3.0 Tesla[J]. J Magn Reson Imaging,2011,34:22-30.
[23] Zou Z, Li R, Zhao X, et al. Validation of 3D multi-contrast black blood sequences with large coverage for one-stop neurovascular screening[C]. Proc Intl Soc Mag Reson Med,2013,21:0877.
[24] Buhk JH, Finck-wedel AK, Buchert R, et al. Screening for atherosclerotic plaques in the abdominal aorta in high-risk patients with multicontrast-weighted MRI:a prospective study at 3.0 and 1.5 tesla[J]. Br J Radiol,2011,84:883-889.
[25] Chi J,Chiu B,Cao Y,et al.Assessment of femoral artery atherosclerosis at the adductor canal using 3D black-blood MRI[J]. Clin Radiol,2013,68:e213-e221.
[26] Chen H,Ricks J,Rosenfeld M,et al.Progression of experimental lesions of atherosclerosis:assessment by kinetic modeling of black-blood dynamic contrast-enhanced MRI[J].Magn Reson Med,2013, 69:1712-1720.
[27] Liu W, Balu N, Sun J, et al. Segmentation of carotid plaque using multicontrast 3D gradient echo MRI[J]. J Magn Reson Imaging,2012,35:812-819.
[28] Inoue Y,Yoneyama M,Nakamura M,et al.Carotid plaque assessment using inversion recovery T1 weighted-3 dimensions variable refocus flip angle turbo spin echo sampling perfection with application optimized contrast using different angle evolutions black blood imaging[J].Nihon Hoshasen Gijutsu Gakkai Zasshi,2012,68(7):880-888.
相似文献/References:
[1]胥雪莲,何川.前蛋白转化酶枯草溶菌素9与动脉粥样硬化[J].心血管病学进展,2016,(1):50.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.013]
XU Xuelian,HE Chuan.Proprotein Convertase Subtilisin/Kexin Type 9 and Atherosclerosis[J].Advances in Cardiovascular Diseases,2016,(1):50.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.013]
[2]阎萌,田芳,综述,等.程序性坏死与动脉粥样硬化[J].心血管病学进展,2016,(2):139.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.011]
YAN Meng,TIAN Fang,TIAN Ye.Necroptosis and Atherosclerosis[J].Advances in Cardiovascular Diseases,2016,(1):139.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.011]
[3]许利冬,综述,李为民,等.左主干解剖形态与左冠状动脉粥样硬化研究新进展[J].心血管病学进展,2016,(2):173.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.020]
XU Lidong,LI Weimin.New Progress Between Left Main Coronary Anatomy and Left Coronary
Atherosclerosis[J].Advances in Cardiovascular Diseases,2016,(1):173.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.020]
[4]陈芡茹,综述,叶飞,等.心血管疾病治疗新目标:脂蛋白相关磷脂酶A2[J].心血管病学进展,2016,(2):188.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.024]
CHEN Qianru,YE Fei.Novel Therapeutic Target of Cardiovascular Disease:Lipoprotein Associated
Phospholipase A2[J].Advances in Cardiovascular Diseases,2016,(1):188.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.024]
[5]蔡鹏,综述,王旭开,等.胰岛素清除率下降机制及其对大血管损伤作用的研究进展[J].心血管病学进展,2016,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.020]
CAI Peng,WANG Xukai.Mechanism and Large Vascular Injury Effect of Insulin Clearance Decrease[J].Advances in Cardiovascular Diseases,2016,(1):292.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.020]
[6]刘欢,刘润冬,综述,等.血管内皮功能的评价及其临床价值[J].心血管病学进展,2016,(4):426.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.026]
LIU Huan,LIU Rundong,WANG Hongyu.Evaluation of Vascular Endothelial Function and Its Clinical Value[J].Advances in Cardiovascular Diseases,2016,(1):426.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.026]
[7]胥雪莲,何川.炎症与动脉粥样硬化[J].心血管病学进展,2015,(5):634.[doi:10.3969/j.issn.1004-3934.2015.05.029]
XU Xuelian,HE Chuan.Inflammation and Atherosclerosis[J].Advances in Cardiovascular Diseases,2015,(1):634.[doi:10.3969/j.issn.1004-3934.2015.05.029]
[8]于洋杰 谢坤 高秀芳 施海明 李勇.非高密度脂蛋白胆固醇可以替代低密度脂蛋白胆固醇吗？[J].心血管病学进展,2021,(1):12.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
YU Yangjie,XIE Kun,GAO Xiufang,et al.Can LDL-C be Replaced by non-HDL-C[J].Advances in Cardiovascular Diseases,2021,(1):12.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[9]于洋杰 谢坤 施海明.血管生成素样蛋白3抑制剂研究进展[J].心血管病学进展,2021,(6):530.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.013]
YU Yangjie,XIE Kun,SHI Haiming.Angiopoietin-like Protein 3 Inhibitors[J].Advances in Cardiovascular Diseases,2021,(1):530.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.013]